TeleflexLogo.jpg
Teleflex Convenes Urologists in Australia for Summit on Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
14 janv. 2020 06h30 HE | Teleflex Incorporated
Minimally Invasive UroLift® System Provides Safe and Effective Symptom Relief for Men with an Enlarged Prostate While Preserving Sexual Function* WAYNE, Pa., Jan. 14, 2020 (GLOBE NEWSWIRE) --...
TeleflexLogo.jpg
Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
07 janv. 2020 06h30 HE | Teleflex Incorporated
WAYNE, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for...
Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate
16 sept. 2019 06h45 HE | Teleflex Incorporated
WAYNE, Pa., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of an article showcasing the effectiveness and overall benefits of the minimally...
TeleflexLogo.jpg
Teleflex Wins New Zealand Innovation Award for UroLift System for Patients with Enlarged Prostate
07 août 2019 06h45 HE | Teleflex Incorporated
Minimally Invasive Treatment Provides Rapid, Durable Symptom Relief Without Compromising Sexual Function* WAYNE, Pa., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today...
TeleflexLogo.jpg
Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System
09 juil. 2019 06h45 HE | Teleflex Incorporated
WAYNE, Pa., July 09, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of positive results from a multi-center study reaffirming the safety and effectiveness...